How do patients with vascular rings/slings die?

K. O. Dubowy, D. Kececioglu, U. Blanz, S. Sarikouch (Bad Oeynhausen, Germany)

Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Session: The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Session type: Thematic Poster Session
Number: 1274
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. O. Dubowy, D. Kececioglu, U. Blanz, S. Sarikouch (Bad Oeynhausen, Germany). How do patients with vascular rings/slings die?. Eur Respir J 2008; 32: Suppl. 52, 1274

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019


Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021



How do patients with COPD and chronic respiratory failure die and what can we do?
Source: Annual Congress 2012 - Advances in chronic respiratory failure in COPD: now out of its infancy
Year: 2012


Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



Pulmonary function in elderly patients with diagnosis of lung cancer – an excuse for giving up surgery?
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013


What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003

How can we stop people with COPD dying?
Source: Annual Congress 2006 - New insights into the worldwide burden of COPD
Year: 2006


Are patients with recurrent pulmonary embolism diagnosed earlier than those with their first episode? Unfortunately not!
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010


TB patients are coming back to hospital – why?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008

Treatment of early lung disease – is it possible? Does it work?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004

How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Source: Eur Respir J, 56 (4) 2003092; 10.1183/13993003.03092-2020
Year: 2020



Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018


Who should treat lung cancer patients and where should they be treated?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009


1 year evolution of COPD patients systemic endothelial dysfunction
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005

Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019


What do patients expect from ERN-LUNG?
Source: International Congress 2018 – Rare lung diseases
Year: 2018